Tsao H, Bevona C, Goggins W, Quinn T
Advances in dual/triple agonists, novel delivery systems, and precision medicine are expanding the therapeutic landscape
With time, the symptoms tend to deteriorate
ACE-inhibitors may contribute to renal dysfunction by activating the renin-angiotensin aldosterone system (RAAS)
Semaglutide-based clinical evidence from a post hoc analysis of the SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) trials (SUSTAIN 15
During this period, cultured chondrocytes gradually lose the proliferative capacity and the potential of generating the cartilage-specific matrix, a phenomenon known as dedifferentiation (Sassi et al., 2014)